Yuma Clinical Trials | Yuma, AZ
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
X0002
Orforglipron
Survodutide
Tirzepatide
Ixekizumab
BI 456906
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 5 total trials
This study will investigate the safety and efficacy of once daily oral treatment with orforglipron compared with placebo on body weight in adult part...
Active, not recruiting
Overweight
Obesity
Drug: Orforglipron
Drug: Placebo
This study is open to adults who are at least 18 years old and have a body mass index (BMI)bof 27 kg/m2 or more. People can take part if they have ca...
Enrolling
Obesity
Drug: Placebo
Drug: survodutide
The main purpose of this study is to demonstrate that when participants with moderate to severe plaque psoriasis and obesity or overweight receive ix...
Enrolling
Psoriasis
Obesity
Drug: Tirzepatide
Drug: Ixekizumab
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems